glpg0187
Small moleculeexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Jun 1, 2009 (NCT00928343)
Timeline
2000s
- Jan 1, 2009
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Fibronectin receptor betaINHIBITOR
ITGB1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- glpg0187
- glpg0187
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01580644 | Phase 1 | Jan 1, 2012 | Galapagos NV, SGS Life Sciences |
| NCT01313598 | Phase 1 | Mar 1, 2011 | Galapagos NV |
| NCT00928343 | Phase 1 | Jun 1, 2009 | Galapagos NV, SGS Life Sciences |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Galapagos NV | For profit | 3 | 3 | 1 | 2009 |
| SGS Life Sciences | For profit | 2 | 0 | 1 | 2009 |
2 organizations
Page 1 / 1